These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 18316390)

  • 1. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
    Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
    Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
    Fowkes FJ; Richards JS; Simpson JA; Beeson JG
    PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody Profiles to
    Ondigo BN; Hamre KES; Frosch AEP; Ayodo G; White MT; John CC
    Am J Trop Med Hyg; 2020 Dec; 103(6):2189-2197. PubMed ID: 33124539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
    Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
    PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.
    Yman V; White MT; Asghar M; Sundling C; Sondén K; Draper SJ; Osier FHA; Färnert A
    BMC Med; 2019 Jan; 17(1):22. PubMed ID: 30696449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
    Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
    Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
    PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.
    Akpogheneta OJ; Dunyo S; Pinder M; Conway DJ
    Parasite Immunol; 2010 Apr; 32(4):296-304. PubMed ID: 20398230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
    Mbengue B; Fall MM; Varela ML; Loucoubar C; Joos C; Fall B; Niang MS; Niang B; Mbow M; Dieye A; Perraut R
    Clin Exp Immunol; 2019 Apr; 196(1):86-96. PubMed ID: 30580455
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Jahnmatz P; Nyabundi D; Sundling C; Widman L; Mwacharo J; Musyoki J; Otieno E; Ahlborg N; Bejon P; Ndungu FM; Färnert A
    Front Immunol; 2022; 13():799306. PubMed ID: 35355994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
    McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
    Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
    Murungi LM; Kamuyu G; Lowe B; Bejon P; Theisen M; Kinyanjui SM; Marsh K; Osier FH
    Vaccine; 2013 Aug; 31(37):3936-42. PubMed ID: 23800539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
    al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
    Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.
    Kangoye DT; Mensah VA; Murungi LM; Nkumama I; Nebie I; Marsh K; Cisse B; Bejon P; Osier FH; Sirima SB;
    Vaccine; 2016 Jan; 34(1):160-6. PubMed ID: 26541134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
    Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
    Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.